UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set

Diabetes care, 2018-07, Vol.41 (7), p.e113-e114

2018

Volltextzugriff (PDF)

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Value in health, 2004-09, Vol.7 (5), p.518-528

2004

Volltextzugriff (PDF)

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

Cardiovascular diabetology, 2018-04, Vol.17 (1), p.54-54, Article 54

2018

Volltextzugriff (PDF)

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States

Endocrinology, diabetes & metabolism, 2019-07, Vol.2 (3), p.e00076-n/a

2019

Volltextzugriff (PDF)

Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective

Gates open research, 2021, Vol.5, p.171-171

2021

Volltextzugriff (PDF)

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

Endocrinology, diabetes & metabolism, 2020-04, Vol.3 (2), p.e00106-n/a

2020

Volltextzugriff (PDF)

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Clinical diabetes and endocrinology, 2020-03, Vol.6 (1), p.5-5, Article 5

2020

Volltextzugriff (PDF)

Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2970-2979

2023

Volltextzugriff (PDF)

Persistence of newer anti-obesity medications in a real-world setting

Diabetes research and clinical practice, 2018-09, Vol.143, p.348-356

2018

Volltextzugriff (PDF)

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system

BMJ open, 2017-11, Vol.7 (11), p.e017583-e017583

2017

Volltextzugriff (PDF)

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

Diabetes care, 2022-12, Vol.45 (12), p.2900-2906

2022

Volltextzugriff (PDF)

A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain

Journal of Pain and Symptom Management, 2004-07, Vol.28 (1), p.72-95

2004

Volltextzugriff (PDF)

Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes

Journal of diabetes and its complications, 2023-08, Vol.37 (8), p.108548-108548, Article 108548

2023

Volltextzugriff (PDF)

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model

Diabetes care, 2020-08, Vol.43 (8), p.1910-1919

2020

Volltextzugriff (PDF)

Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes

The American journal of managed care, 2021-12, Vol.27 (20 Suppl), p.S369-S374

2021

Volltextzugriff (PDF)

Drug-drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors

Expert review of anticancer therapy, 2024-05, Vol.24 (5), p.325-333

2024

Volltextzugriff (PDF)

Adverse events and costs among non-metastatic castration-resistant prostate cancer patients

Journal of medical economics, 2024, Vol.27 (1), p.145-152

2024

Volltextzugriff (PDF)

Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database

Journal of nephrology, 2023-01, Vol.36 (1), p.45-54

2023

Volltextzugriff (PDF)

Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis

Clinical kidney journal, 2023-12, Vol.16 (12), p.2461-2471

2023

Volltextzugriff (PDF)

Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population

Journal of managed care & specialty pharmacy, 2023-01, Vol.29 (1), p.80-89

2023

Volltextzugriff (PDF)

Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers

Journal of managed care & specialty pharmacy, 2024-07, Vol.30 (7), p.672-683

2024

Volltextzugriff (PDF)

Exploring kidney dialysis costs in the United States: a scoping review

Journal of medical economics, 2024, Vol.27 (1), p.618-625

2024

Volltextzugriff (PDF)

Decreasing incidence of Type 2 diabetes mellitus in the United States, 2007 to 2012: Epidemiologic findings from a large US claims database

Diabetes research and clinical practice, 2016-07, Vol.117, p.111-118

2016

Volltextzugriff (PDF)

Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors

Journal of diabetes and its complications, 2022-05, Vol.36 (5), p.108180-108180, Article 108180

2022

Volltextzugriff (PDF)

Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System

Diabetes care, 2020-08, Vol.43 (8), p.1937-1940

2020

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(99)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(54)
Male
(33)
Female
(30)
Aged
(29)
Middle Aged
(24)
Pharmacology & Pharmacy
(24)
Adult
(22)
Biological And Medical Sciences
(20)
Health Care Sciences & Services
(20)
Medical Sciences
(19)
Diabetes
(18)
Endocrinology & Metabolism
(16)
Health Policy & Services
(16)
Pharmacology. Drug Treatments
(16)
Anti-Inflammatory Agents, Non-Steroidal - Therapeutic Use
(14)
Retrospective Studies
(13)
General & Internal Medicine
(12)
Osteoarthritis - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States

Quantifying the economic burden of unintended pregnancies due to drug-drug interactions with hormonal contraceptives from the United States payer perspective

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020

Persistence of newer anti-obesity medications in a real-world setting

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain

Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model

Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes

Drug-drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors

Adverse events and costs among non-metastatic castration-resistant prostate cancer patients

Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database

Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis

Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population

Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers

Exploring kidney dialysis costs in the United States: a scoping review

Decreasing incidence of Type 2 diabetes mellitus in the United States, 2007 to 2012: Epidemiologic findings from a large US claims database

Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors

Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System

Suchergebnisse filtern